Law360, New York (October 27, 2011, 9:23 PM ET) -- The plaintiffs' steering committee in multidistrict litigation over Bayer Corp. birth control pills Yaz and Yasmin asked an Illinois federal judge Thursday for authority to present the U.S. Food and Drug Administration with confidential documents about the health risks of pills containing drospirenone.
The steering committee filed the motion on behalf of plaintiff Kaitlyn Dietrick, arguing that the First Amendment guarantees her the right to present documents currently classified as confidential to a joint meeting of the FDA and its advisory committees Dec. 8 addressing the...
Yaz MDL Plaintiffs Say FDA Should See Confidential Docs
To view the full article, take a free trial now.
